Clinical trial
Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow…
NCT00437554 · Handok Inc., Industry · Completed
Key facts
| NCT number | NCT00437554 |
|---|---|
| Title | Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR) |
| Official title | A 16-Week Controlled, Double Blind, Double Dummy, Randomized, Two Arm Parallel-Group Study to Compare the Efficacy and Safety of Amaryl M 1/250 mg b.i.d vs. Amaryl M SR 2/500 mg od. in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Handok Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Glimepiride |
| Enrollment | 188 |
| Start date | Aug 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Feb 21, 2007 |
| Last update posted | Nov 29, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: